Pidilite FY26 ends strong as Q4 volumes surge, but FY27 starts with input cost pressure

Pidilite Industries closed FY26 with a strong finish. In Q4 FY26, standalone net sales rose to Rs 3,272 crore, up 15.3% year on year, backed by underlying volume growth of 15.3%. Profitability improved sharply. Standalone EBITDA grew 31.1% to Rs 766 crore, with EBITDA margin expanding to 23.4% from 20.6% a year ago.

On a full year basis, standalone net sales were Rs 13,437 crore, up 11.8%, while EBITDA increased 16.4% to Rs 3,300 crore. PAT rose 15.0% to Rs 2,384 crore. Consolidated performance broadly tracked the standalone trajectory. Consolidated net sales were Rs 14,553 crore, up 11.1%, and consolidated PAT was Rs 2,471 crore, up 17.9%.

What drove Q4 outperformance

The quarter was broad based. Consumer and Bazaar recorded underlying volume growth of 15.4%, and Business to Business posted 14.8%. Management highlighted that the only meaningful disruption was in exports, where March shipments were impacted by the conflict in the Gulf and West Asia.

Within the standalone segment view, Consumer and Bazaar revenue from operations in Q4 was Rs 2,561 crore with PBIT of Rs 785 crore. B2B revenue from operations was Rs 752 crore with PBIT of Rs 146 crore. Management commentary suggested that growth brands such as Roff and Dr. Fixit continued strong momentum, while core categories also performed well, including double digit growth in Fevicol during the quarter.

Margin expansion and the moving parts

The Q4 margin story was supported by both gross margin and operating leverage. Gross margin improved to 55.6%, around 100 basis points higher year on year. Management also noted tight control on costs below the margin line, enabling EBITDA margin expansion.

However, the quarter also showed how non operating lines can shift the optics. Other income as a percentage of sales was lower by around 230 basis points, attributed to lower investment returns due to rising bond yields and a dividend timing difference. The presentation noted that dividend income from subsidiaries in Q4 was nil versus Rs 37 crore in Q4 FY25.

Subsidiaries, exports, and category realities

On subsidiaries, Q4 performance was positive but uneven. Domestic subsidiaries grew 5.3% and international subsidiaries grew 7.8% during the quarter. The domestic subsidiary picture split sharply by business type. In FY26, domestic subsidiaries Consumer and Bazaar net sales rose 17.1% to Rs 586 crore with EBITDA up 28.7% to Rs 89 crore. Domestic subsidiaries B2B net sales declined 5.1% to Rs 359 crore and EBITDA fell 41.0% to Rs 18 crore.

Overseas subsidiary reporting in the presentation was shown by geography. For FY26, Middle East and Africa net sales were Rs 341 crore, up 5.5%, with EBITDA down 6.2% to Rs 29 crore. Asia net sales were Rs 359 crore, up 7.0%, with EBITDA up 24.9% to Rs 78 crore.

Exports were a key talking point on the concall. Management attributed March disruption to the West Asia conflict and said supply chains were impacted. The company indicated it is exploring alternate sourcing routes and suppliers to maintain continuity.

FY27 begins with inflation, pricing actions, and guarded confidence

The central FY27 debate on the concall was input cost inflation. Management stated that at current replacement prices, weighted average raw material inflation was around 40% to 50%. They said the strategy is to pass on absolute increases in rupee terms in a calibrated fashion, with the focus remaining on growth and disciplined demand generation.

Two rounds of pricing actions were described. At a blended company level, management stated they took a price increase of around 4% to 5% in mid April and another 7% to 8% in early May. For the Fevicol division, management cited about a 5% increase in April and a follow up of 7% to 9% in early May, varying by product.

On margins, management reiterated commitment to an EBITDA margin corridor of 20% to 24%. They noted FY26 was at the higher end due to benign inputs, while FY27 would be different given inflation. They did not provide a firm volume growth outlook for FY27, repeatedly emphasizing that it is a unique year and performance needs monitoring over shorter intervals.

Capital allocation, capex discipline, and shareholder payout

Management stated that capex typically remains in the 3% to 5% of revenue range. They also said the company plans capacity and automation rigorously to avoid shelf availability issues. A specific milestone mentioned was commissioning a large plant in West India for premium white glue and Fevicol in Q1 FY27.

On shareholder returns, the corporate announcement stated that the board recommended a final dividend of Rs 11.50 per equity share for FY26, subject to shareholder approval. The investor presentation added that this follows a special interim dividend, and the total dividend payout ratio for FY26 is about 70%.

Takeaways

Pidilite ended FY26 with strong volume led growth and a sharp Q4 margin recovery. Segment performance was broad based, with Consumer and Bazaar continuing to accelerate and B2B staying resilient despite export disruption. The FY27 setup is more volatile. Management has already initiated pricing, is working on supply security, and reiterated its margin corridor. The next few quarters will test how smoothly pricing, demand, and input costs adjust.